Global Digital Diabetes Management Market to Signify Strong Growth by 2022-2028

The global digital diabetes management market is anticipated to grow at a significant CAGR of 19.6% during the forecast period. The increasing prevalence of diabetes has increased the growth of the digital diabetes management market globally. According to the International Diabetes Federation (IDF), in December 2021, approximately 537 million adults (20-79 years) were living with diabetes. Diabetes caused at least 966 billion dollars in health expenditure, 9% of total spending on adults. Moreover, advancements in technologies and adoption of cloud-based diabetes management solutions is further projected to create scope for the market growth. However, the high cost of digital devices and lack of availability of advanced technology in a developing country, restrain the growth of the digital diabetes management market.

Get Free Sample link @ https://www.omrglobal.com/request-sample/digital-diabetes-management-market

During COVID-19 there was a complete shutdown across the globe due to strict government rules and regulations to stop the spread of the virus. The manufacturing of non-essential products and devices was closed for some time due to which the global digital diabetes management market growth witnessed a negative impact during the COVID-19.

A full report of Global Digital Diabetes Management Market available @ https://www.omrglobal.com/industry-reports/digital-diabetes-management-market

  • Market Coverage
  • Market number available for – 2022-2028
  • Base year- 2021
  • Forecast period- 2022-2028
  • Segment Covered- By Source, By Product Type, By Applications
  • Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others

Market Segmentation

Global Digital Diabetes Management Market by Product 

  • Smart Glucometer
  • Smart CGM
  • Insulin Patch Pump
  • Diabetes Apps

Global Digital Diabetes Management Market by Device Type 

  • Handheld
  • Wearables

Global Digital Diabetes Management Market by End-User

  • Hospitals
  • Homecare

Regional Analysis

  • North America
  • US
  • Canada
  • Europe
  • UK
  • Germany
  • Italy
  • Hospitalsin
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World

Company Profiles 

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • ARKRAY
  • Ascensia Diabetes Care Holdings AG
  • Azumio Inc.
  • Care Innovations, LLC
  • DarioHealth Corp.
  • decide Clinical Software GmbH
  • Emperra GmbH E-Health Technologies
  • Glooko, Inc.
  • H2 Inc. (Health2Sync)
  • Insulet Corp.
  • LifeScan
  • One Drop ? Informed Data Systems, Inc.
  • Pendiq GmbH
  • Tidepool Project
  • Ypsomed AG

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global digital diabetes management market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/digital-diabetes-management-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404